Vermont 2023-2024 Regular Session

Vermont House Bill H0439

Introduced
3/1/23  

Caption

An act relating to decriminalizing certain chemical compounds found in plants and fungi that are commonly used for medicinal, spiritual, religious, or entheogenic purposes

Impact

The implications of this bill are significant, as it changes how the state handles substances that have been historically classified as illegal or regulated. By decriminalizing these substances, Vermont would join a growing number of states and jurisdictions that have taken steps toward marijuana reform and the acceptance of psychedelics for therapeutic use. This legislation may pave the way for increased research into the benefits of these substances and foster a more accepting public discourse around their use in the context of mental health, addiction treatment, and personal wellness.

Summary

House Bill H0439 proposes the decriminalization of certain chemical compounds found in plants and fungi that are typically used for medicinal, spiritual, religious, or entheogenic purposes. The bill aims to amend existing laws, specifically the definitions within the state's drug regulations, to exclude substances such as peyote, ayahuasca, mescaline, psilocybin, and ibogaine from the list of regulated drugs. If enacted, this bill would legally allow individuals and certain practitioners to utilize these substances without fear of prosecution under state law, provided they meet specific contexts related to medicinal or spiritual practices.

Contention

Points of contention surrounding this bill are likely to arise regarding public safety, potential misuse, and the ethical considerations of promoting substances that can alter consciousness. Opponents may express concerns about the lack of regulation and oversight on the use of these substances, fearing that decriminalization could lead to unintended consequences such as abuse or a rise in recreational use. Additionally, discussions may also involve the bill's implications for healthcare providers and practitioners on how they can ethically and legally guide patients in using these substances.

Companion Bills

No companion bills found.

Previously Filed As

VT H0371

An act relating to removal of criminal penalties for possessing, dispensing, or selling psilocybin and establishment of the Psychedelic Therapy Advisory Working Group

VT H0189

An act relating to funding support services for persons who use drugs and eliminating misdemeanor criminal penalties for possessing or dispensing a personal use drug supply

VT SB0499

Controlled substances: penalties; conduct associated with entheogenic plants and fungi; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.).

VT SB2184

USE AND RESEARCH-ENTHEOGENS

VT H0423

An act relating to a public health response to drug use

VT S0300

An act relating to funding support services for persons who use drugs and eliminating misdemeanor criminal penalties for possessing or dispensing a personal use drug supply

VT S0120

An act relating to funding support services for persons who use drugs and eliminating misdemeanor criminal penalties for possessing or dispensing a personal use drug supply

VT H0152

An act relating to regulating products containing certain chemicals and chemical classes

VT S0114

An act relating to the establishment of the Psychedelic Therapy Advisory Working Group

VT H1624

Establishing a task force to study equitable access to psilocybin and other entheogenic plants

Similar Bills

No similar bills found.